CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
8.75
+0.28 (3.31%)
Jul 2, 2026, 10:30 AM EDT - Market open
CorMedix Employees
CorMedix had 191 employees as of December 31, 2025. The number of employees increased by 126 or 193.85% compared to the previous year.
Employees
191
Change (1Y)
126
Growth (1Y)
193.85%
Revenue / Employee
$2,094,524
Profits / Employee
$942,534
Market Cap
686.45M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 191 | 126 | 193.85% | 191 | 0 |
| Dec 31, 2024 | 65 | -18 | -21.69% | 64 | 1 |
| Dec 31, 2023 | 83 | 42 | 102.44% | 82 | 1 |
| Dec 31, 2022 | 41 | 11 | 36.67% | 40 | 1 |
| Dec 31, 2021 | 30 | -5 | -14.29% | 29 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 625 |
| REGENXBIO | 371 |
| ProKidney | 231 |
| BridgeBio Oncology Therapeutics | 106 |
| Tectonic Therapeutic | 60 |
| Altimmune | 57 |
| Crescent Biopharma | 55 |
CRMD News
- 9 days ago - CorMedix Transcript: AGM 2026 - Transcripts
- 24 days ago - CorMedix announces United States Court of Appeals affirms patent judgements - TheFly
- 24 days ago - U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation - GlobeNewsWire
- 4 weeks ago - CorMedix Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - CorMedix Slides: Corporate presentation - Filings
- 6 weeks ago - CorMedix Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Cormedix Therapeutics to Participate in two Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - CorMedix Earnings Call Transcript: Q1 2026 - Transcripts